Distributed Bio is an immuno-engineering company that provides computational tools, antibody libraries, and more. The company's mission is to develop breakthrough technologies to drug previously challenging targets like GPCRs, ion channels, pMHC complexes, condition-specific binders, anti-idiotypes, and broadly neutralizing viral epitopes. The combination of computational immunology, bioengineering, and robotics has allowed the company to develop a pipeline of molecules with unprecedented biophysical properties, while also supporting all of the partners with thousands of high affinity developable antibodies against any drug target of interest.

Distributed Bio was founded on 2010 and is headquartered in San Francisco, California.